Dynavax Net Debt from 2010 to 2024

DVAX Stock

USD 12.36 0.19 1.56%

Dynavax Technologies Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Dynavax Technologies minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2003-12-31

Previous Quarter

142.8 M

Current Value

130.8 M

Quarterly Volatility

72.6 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 4 M or Other Operating Expenses of 282.8 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.

Check out the analysis of Dynavax Technologies Correlation against competitors.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Net Debt Growth Pattern

Below is the plot of the Net Debt of Dynavax Technologies over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Dynavax Technologies' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Dynavax Net Debt Regression Statistics

	Arithmetic Mean	21,266,717
	Coefficient Of Variation	446.90
	Mean Deviation	74,782,193
	Median	(7,599,000)
	Standard Deviation	95,040,789
	Sample Variance	9032.8T
	Range	364.6M
	R-Value	0.41
	Mean Square Error	8057.5T
	R-Squared	0.17
	Significance	0.12
	Slope	8,805,669
	Total Sum of Squares	126458.5T

Dynavax Net Debt History

	2024	112 M
	2023	106.6 M
	2022	56 M
	2021	-178.8 M
	2020	185.8 M
	2019	176.6 M
	2018	51.5 M

Other Fundumenentals of Dynavax Technologies

Net Debt To E B I T D A

Dynavax Technologies Net Debt component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.85	-0.49	0.86	0.13	0.8	0.19	0.91	0.62	0.11	0.97	0.84	-0.57	-0.1	0.87	-0.3	0.83	0.78	0.77	0.81	-0.61	0.86	0.9	0.93
Total Stockholder Equity	0.85		-0.21	0.48	0.04	0.96	0.21	0.61	0.2	0.18	0.93	0.59	-0.54	-0.16	0.61	-0.14	0.99	0.59	0.52	0.59	-0.74	0.87	0.94	0.73
Retained Earnings	-0.49	-0.21		-0.63	-0.67	-0.26	0.02	-0.74	-0.39	-0.36	-0.41	-0.41	0.46	-0.1	-0.7	0.7	-0.11	-0.83	-0.74	-0.8	0.12	-0.27	-0.25	-0.57
Total Liab	0.86	0.48	-0.63		0.19	0.43	0.12	0.95	0.85	0.01	0.75	0.84	-0.44	-0.01	0.88	-0.37	0.45	0.74	0.8	0.8	-0.32	0.62	0.61	0.87
Accounts Payable	0.13	0.04	-0.67	0.19		0.17	-0.08	0.36	-0.1	0.54	0.14	-0.03	-0.4	0.15	0.41	-0.42	-0.02	0.55	0.5	0.55	-0.07	0.09	0.06	0.19
Short Term Investments	0.8	0.96	-0.26	0.43	0.17		0.2	0.59	0.07	0.4	0.91	0.44	-0.54	-0.1	0.66	-0.13	0.96	0.6	0.6	0.61	-0.84	0.81	0.94	0.72
Common Stock	0.19	0.21	0.02	0.12	-0.08	0.2		0.09	0.15	-0.01	0.19	0.19	0.5	-0.17	0.09	0.52	0.19	0.05	0.05	-0.03	0.0	0.19	0.12	0.17
Property Plant Equipment	0.91	0.61	-0.74	0.95	0.36	0.59	0.09		0.72	0.15	0.83	0.77	-0.6	-0.09	0.91	-0.48	0.57	0.86	0.84	0.91	-0.47	0.67	0.72	0.9
Current Deferred Revenue	0.62	0.2	-0.39	0.85	-0.1	0.07	0.15	0.72		-0.47	0.46	0.73	-0.15	-0.11	0.51	-0.23	0.18	0.45	0.4	0.49	-0.02	0.36	0.32	0.58
Net Debt	0.11	0.18	-0.36	0.01	0.54	0.4	-0.01	0.15	-0.47		0.2	-0.14	-0.23	0.14	0.46	-0.11	0.18	0.36	0.54	0.36	-0.36	0.18	0.25	0.31
Total Current Assets	0.97	0.93	-0.41	0.75	0.14	0.91	0.19	0.83	0.46	0.2		0.71	-0.59	-0.09	0.82	-0.24	0.92	0.73	0.74	0.76	-0.75	0.87	0.97	0.89
Net Receivables	0.84	0.59	-0.41	0.84	-0.03	0.44	0.19	0.77	0.73	-0.14	0.71		-0.39	-0.12	0.72	-0.25	0.55	0.63	0.59	0.68	-0.14	0.75	0.57	0.81
Good Will	-0.57	-0.54	0.46	-0.44	-0.4	-0.54	0.5	-0.6	-0.15	-0.23	-0.59	-0.39		-0.05	-0.57	0.54	-0.51	-0.53	-0.55	-0.66	0.57	-0.45	-0.59	-0.5
Intangible Assets	-0.1	-0.16	-0.1	-0.01	0.15	-0.1	-0.17	-0.09	-0.11	0.14	-0.09	-0.12	-0.05		0.09	-0.09	-0.15	0.03	0.31	-0.05	0.01	-0.13	-0.11	-0.14
Long Term Debt	0.87	0.61	-0.7	0.88	0.41	0.66	0.09	0.91	0.51	0.46	0.82	0.72	-0.57	0.09		-0.4	0.59	0.85	0.97	0.89	-0.51	0.71	0.74	0.94
Short Term Debt	-0.3	-0.14	0.7	-0.37	-0.42	-0.13	0.52	-0.48	-0.23	-0.11	-0.24	-0.25	0.54	-0.09	-0.4		-0.07	-0.61	-0.41	-0.58	0.05	-0.17	-0.14	-0.31
Net Tangible Assets	0.83	0.99	-0.11	0.45	-0.02	0.96	0.19	0.57	0.18	0.18	0.92	0.55	-0.51	-0.15	0.59	-0.07		0.53	0.49	0.54	-0.77	0.86	0.95	0.71
Capital Surpluse	0.78	0.59	-0.83	0.74	0.55	0.6	0.05	0.86	0.45	0.36	0.73	0.63	-0.53	0.03	0.85	-0.61	0.53		0.83	0.96	-0.31	0.73	0.61	0.84
Deferred Long Term Liab	0.77	0.52	-0.74	0.8	0.5	0.6	0.05	0.84	0.4	0.54	0.74	0.59	-0.55	0.31	0.97	-0.41	0.49	0.83		0.85	-0.49	0.6	0.65	0.83
Long Term Debt Total	0.81	0.59	-0.8	0.8	0.55	0.61	-0.03	0.91	0.49	0.36	0.76	0.68	-0.66	-0.05	0.89	-0.58	0.54	0.96	0.85		-0.37	0.73	0.66	0.88
Short Long Term Debt	-0.61	-0.74	0.12	-0.32	-0.07	-0.84	0.0	-0.47	-0.02	-0.36	-0.75	-0.14	0.57	0.01	-0.51	0.05	-0.77	-0.31	-0.49	-0.37		-0.46	-0.85	-0.5
Net Invested Capital	0.86	0.87	-0.27	0.62	0.09	0.81	0.19	0.67	0.36	0.18	0.87	0.75	-0.45	-0.13	0.71	-0.17	0.86	0.73	0.6	0.73	-0.46		0.85	0.85
Net Working Capital	0.9	0.94	-0.25	0.61	0.06	0.94	0.12	0.72	0.32	0.25	0.97	0.57	-0.59	-0.11	0.74	-0.14	0.95	0.61	0.65	0.66	-0.85	0.85		0.82
Capital Stock	0.93	0.73	-0.57	0.87	0.19	0.72	0.17	0.9	0.58	0.31	0.89	0.81	-0.5	-0.14	0.94	-0.31	0.71	0.84	0.83	0.88	-0.5	0.85	0.82

Click cells to compare fundamentals

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	106.6 M	112 M
Net Debt To EBITDA	11.03	11.58

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dynavax Net Debt from 2010 to 2024

Latest Dynavax Technologies' Net Debt Growth Pattern

Dynavax Net Debt Regression Statistics

Dynavax Net Debt History

Other Fundumenentals of Dynavax Technologies

Dynavax Technologies Net Debt component correlations

About Dynavax Technologies Financial Statements

Also Currently Popular

Additional Tools for Dynavax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY